ロード中...
Population-based estimates of survival and cost for metastatic melanoma
BACKGROUND: Fewer than half of all patients with metastatic melanoma survive more than 1 year. Standard treatments have had little success, but recent therapeutic advances offer the potential for an improved prognosis. In the present study, we used population-based administrative data to establish r...
保存先:
| 出版年: | Curr Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Multimed Inc.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608398/ https://ncbi.nlm.nih.gov/pubmed/26628865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.22.2557 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|